Calls Purchased on Isis Pharmaceuticals (ISIS)
April 07, 2011 11:29 AM
Shares of Isis Pharmaceuticals (NASDAQ: ISIS) are higher on the session by 0.65%, currently trading at $9.29. The stock has been moving largely lower over the past four months, but it is currently trading above the 50-day moving average.
Options traders are buying calls on the name today. Though action has been primarily in small lots, overall call volume is now running at 6.28x the daily average with 98% of all calls traded being purchases on the offer.
Traders are buying the $12.00 strike in multiple months.
Isis Pharmaceuticals, Inc. is engaged in antisense technology, exploiting a drug discovery platform created to generate first-in-class drugs. The company operates in two business segments: Drug Discovery and Development, and Regulus Therapeutics Inc.
